PMID- 31694243 OWN - NLM STAT- MEDLINE DCOM- 20200325 LR - 20200325 IS - 1420-3049 (Electronic) IS - 1420-3049 (Linking) VI - 24 IP - 21 DP - 2019 Nov 5 TI - Oleanolic Acid Acetate Exerts Anti-Inflammatory Activity via IKKalpha/beta Suppression in TLR3-Mediated NF-kappaB Activation. LID - 10.3390/molecules24214002 [doi] LID - 4002 AB - Oleanolic acid acetate (OAA), a major triterpenoid compound of Vigna angularis (azuki bean, V. angularis), has been shown to downregulate inflammatory responses in macrophages. Here, we show the molecular basis for the effect of OAA on Toll-like receptor (TLR) downstream signaling. OAA treatment significantly inhibited the secretion of embryonic alkaline phosphatase (SEAP) induced by polyinosinic acid (poly(I), TLR3 ligand) in a dose-dependent manner and without cytotoxicity in THP1-XBlue cells. In addition, OAA downregulated the gene expression of poly(I) induced pro-inflammatory cytokines and chemokines genes such as MCP-1, IL-1beta, IL-8, VCAM-1 and ICAM-1. Furthermore, we found that the inhibition activity of OAA was accompanied by decreased activation of not only nuclear factor-kappa B (NF-kappaB) signaling but also mitogen-activated protein kinase (MAPK) signaling upon stimulation with the TLR3 agonist. Interestingly, the interaction of OAA with IkappaB kinase alpha/beta (IKKalpha/beta) strongly attenuated the production of certain proteins and inflammatory cytokines in the TLR3 signaling pathway, such as nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IkBalpha), extracellular regulated kinases (ERK), and p38, in an in vitro model. The action of OAA was regulated by TLR3, demonstrating that TLR3 plays a critical role in mediating the physiologically-relevant anti-inflammatory action of OAA and that the interaction with IKKalpha/beta is modulated through TLR3. These results reveal new insight into the understanding of the regulatory mechanisms of the downstream TLR3 signaling pathway and consequent inflammatory responses that are involved in the development and progression of inflammatory diseases. FAU - Lim, Hyung Jin AU - Lim HJ AD - Immunoregulatory Material Research Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si 56212, Korea. AD - Department of Bioactive Material Sciences, Chonbuk National University, Jeonju-si 54896, Korea. FAU - Jang, Hyun-Jae AU - Jang HJ AUID- ORCID: 0000-0002-4383-4465 AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, 30 Yeongudanji-ro, Cheongju-si 28116, Korea. FAU - Kim, Mi Hwa AU - Kim MH AD - Immunoregulatory Material Research Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si 56212, Korea. FAU - Lee, Soyoung AU - Lee S AD - Immunoregulatory Material Research Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si 56212, Korea. FAU - Lee, Seung Woong AU - Lee SW AUID- ORCID: 0000-0003-1025-7363 AD - Immunoregulatory Material Research Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si 56212, Korea. FAU - Lee, Seung-Jae AU - Lee SJ AD - Immunoregulatory Material Research Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si 56212, Korea. FAU - Rho, Mun-Chual AU - Rho MC AD - Immunoregulatory Material Research Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si 56212, Korea. LA - eng GR - P0000811/Korea Institute for Advancement of Technology/ GR - 2015K000281/Ministry of Science, ICT and Future Planning/ GR - KGS9531911/Korea Research Institute of Bioscience and Biotechnology/ GR - KGS1081911/Korea Research Institute of Bioscience and Biotechnology/ PT - Journal Article DEP - 20191105 PL - Switzerland TA - Molecules JT - Molecules (Basel, Switzerland) JID - 100964009 RN - 0 (Acetates) RN - 0 (Anti-Inflammatory Agents) RN - 0 (Cytokines) RN - 0 (NF-kappa B) RN - 0 (TLR3 protein, human) RN - 0 (Toll-Like Receptor 3) RN - 6SMK8R7TGJ (Oleanolic Acid) RN - EC 2.7.11.10 (I-kappa B Kinase) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Acetates/*pharmacology MH - Anti-Inflammatory Agents/*pharmacology MH - Cell Line MH - Cytokines/metabolism MH - Down-Regulation/drug effects MH - Gene Expression/drug effects MH - Humans MH - I-kappa B Kinase/*metabolism MH - Inflammation/*drug therapy/metabolism MH - Macrophages/drug effects/metabolism MH - Mitogen-Activated Protein Kinases/metabolism MH - NF-kappa B/*metabolism MH - Oleanolic Acid/*pharmacology MH - Signal Transduction/drug effects MH - Toll-Like Receptor 3/*metabolism PMC - PMC6866124 OTO - NOTNLM OT - IkappaB kinase alpha/beta OT - Vigna angularis OT - inflammatory cytokines OT - oleanolic acid acetate OT - toll-like receptors COIS- The authors declare no conflicts of interest. EDAT- 2019/11/07 06:00 MHDA- 2020/03/26 06:00 PMCR- 2019/11/05 CRDT- 2019/11/08 06:00 PHST- 2019/10/02 00:00 [received] PHST- 2019/11/04 00:00 [revised] PHST- 2019/11/04 00:00 [accepted] PHST- 2019/11/08 06:00 [entrez] PHST- 2019/11/07 06:00 [pubmed] PHST- 2020/03/26 06:00 [medline] PHST- 2019/11/05 00:00 [pmc-release] AID - molecules24214002 [pii] AID - molecules-24-04002 [pii] AID - 10.3390/molecules24214002 [doi] PST - epublish SO - Molecules. 2019 Nov 5;24(21):4002. doi: 10.3390/molecules24214002.